calendar

5 catalysts · 5,627 phase readout · 2,292 8k filing · 240 earnings · 3 pdufa · 2 approval · 1 adcom

next 91 dayslessmore

MonWedFri

view

sort

Week of Jul 13, 2026

1

Jul 17, 2026pdufa20d agoPDUFA — 2026-07-17

Prescription Drug User Fee Act goal date of July 17, 2026

1

Jan 4, 2027pdufa151dPDUFA — 2027-01-04

action date of January 4, 2027

1

Jan 21, 2027pdufa168dPDUFA — 2027-01-21Ultragenyx Pharmaceutical Inc.

action date of Jan. 21, 2027

2

TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

TBDapprovalTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

$RARE25.81+3.16%

$ABBV243.80-0.53%

$NVS153.27-0.26%